AbbVie | ABBV - Aktiva





Aktiva Perubahan Tanggal
AbbVie USD 135.12B 1.35B 2026-06
Abbott USD 110.43B 23.72B 2026-03
ALKERMES USD 4.39B 135.05M 2026-06
Amgen USD 95.64B 3.14B 2026-06
AstraZeneca USD 119.92B 4.09B 2026-09
Biogen USD 32.05B 32.5M 2026-09
BioMarin Pharmaceutical USD 11.57B 154.21M 2026-09
Bristol-Myers Squibb USD 88.77B 1.14B 2026-09
Coherus Biosciences USD 191.18M 74.84M 2026-06
Eisai JPY 1.56T 108.98B 2026-06
Eli Lilly USD 148.07B 5.79B 2026-09
Gilead Sciences USD 51.41B 2.05B 2026-09
GlaxoSmithKline GBP 71.7B 9.96B 2026-09
J&J USD 197.42B 3.64B 2026-09
Medtronic USD 93.31B 278M 2026-06
Merck USD 129.8B 1.12B 2026-06
Neurocrine Biosciences USD 5.63B 268.3M 2026-09
Novartis USD 117.15B 4.88B 2026-09
Pacira USD 1.24B 35.44M 2026-06
Perrigo USD 7.61B 373.8M 2026-06
Pfizer USD 201.13B 6.49B 2026-06
Regeneron Pharmaceuticals USD 44.41B 2.67B 2026-09
Roche Holding CHF 98.2B 2.5B 2026-06
Sanofi EUR 130.29B 1.23B 2026-09
UCB EUR 18.16B 971M 2025-12
Ultragenyx Pharmaceutical USD 1.26B 32M 2026-06
United Therapeutics USD 7.22B 505.9M 2026-06
Vertex Pharmaceuticals USD 32.74B 5.31B 2026-09
Zoetis USD 15.08B 77M 2026-06